3 recruiting, 2 active not recruiting, 2 not yet recruiting, 1 completed. 3 Phase 3, 2 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Active not recruiting 1, Not yet recruiting 1, Recruiting 1 |
| Phase 2 | 2 | Completed 1, Not yet recruiting 1 |
| Not applicable | 1 | Enrolling by invitation 1 |
Follow Myasthaenia Gravis: new trials by email Literature Review of Myasthaenia Gravis trials Research Report on Myasthaenia Gravis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101 KYV-101 - Refractory Lupus Nephritis, Myasthaenia Gravis | Recruiting | Kyverna Therapeutics | 70 | 2025-11-24 | 2026-02-11 | |
| The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period. Assistive gait devices combined with physiotherapy - Inclusion Body Myositis, Myotonic Dystrophy 1 | Not applicable | Enrolling by invitation | LMU Klinikum | 30 | 2025-09-01 | 2025-07-18 |
| Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia Gravis Decartes-08, Placebo Drug - Myasthaenia Gravis | Phase 3 | Active not recruiting | Cartesian Therapeutics | 128 | 2025-05-06 | 2026-09-01 |
| Neuromuscular Complications of MEK Inhibitors: a French Case Series and a Systematic Review of the Literature No Interventions - Myositis, Myasthaenia Gravis | Not yet recruiting | Central Hospital, Nancy, France | 5 | 2025-03-01 | 2025-02-18 | |
| Efgartigimod in IVIG Dependent Myasthenia Gravis Patients efgartigimod administration - Myasthaenia Gravis | Phase 3 | Recruiting | Clinique Neuro-Outaouais | 30 | 2025-02-06 | 2026-10-22 |
| Blinatumomab in Refractory Myasthenia Gravis (BLINA-MG) Blinatumomab - Myasthaenia Gravis | Phase 2 / Phase 3 | Not yet recruiting | Zhongming Qiu | 10 | 2024-11-30 | 2024-11-12 |
| Characteristics and Prognostic Outcomes of Diaphragmatic Ultrasound in Myasthenia Gravis Myasthaenia Gravis | Active not recruiting | First Affiliated Hospital of Chongqing Medical University | 100 | 2024-07-01 | 2024-11-27 | |
| A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease There is no intervention in this study - Gut Microbiome, Gastrointestinal Microbiome | Suspended | ProgenaBiome | 1000 | 2019-07-11 | 2026-09-21 | |
| Myasthenia Gravis Foundation of America Global MG Patient Registry Myasthaenia Gravis, Myasthenia | Recruiting | Myasthenia Gravis Foundation of America | 3800 | 2013-10-12 | 2024-09-27 | |
| The Evaluation of Belimumab in Myasthenia Gravis (MG) Belimumab, Placebo - Myasthaenia Gravis | Phase 2 | Completed | GlaxoSmithKline | 40 | 2013-04-01 | 2017-02-09 |
Myasthenia Gravis (4) · Arthritis, Rheumatoid (2) · Guillain-Barre Syndrome (2) · Multiple Sclerosis (2) · Acne Vulgaris (1) · Alzheimer Disease (1) · Amyotrophic Lateral Sclerosis (1) · Anxiety Disorders (1) · Autism Spectrum Disorder (1) · Autistic Disorder (1) · Bipolar Disorder (1) · Bipolar and Related Disorders (1) · Brachial Plexus Neuritis (1) · Celiac Disease (1) · Colitis, Ulcerative (1)
Autoimmune Diseases (7) · Autoimmune Diseases of the Nervous System (7) · Immune System Diseases (7) · Nervous System Diseases (7) · Neuromuscular Diseases (6) · Neoplasms by Site (5) · Nervous System Neoplasms (5) · Neurodegenerative Diseases (5) · Neuromuscular Junction Diseases (5) · Paraneoplastic Syndromes (5) · Paraneoplastic Syndromes, Nervous System (5) · Demyelinating Diseases (4) · Muscular Diseases (4) · Musculoskeletal Diseases (4) · Neoplasms (4)
Physical Therapy Modalities (1) · belimumab (1) · blinatumomab (1) · efgartigimod alfa (1)
Cartesian Therapeutics (1) · Central Hospital, Nancy, France (1) · Clinique Neuro-Outaouais (1) · First Affiliated Hospital of Chongqing Medical University (1) · GlaxoSmithKline (1) · Kyverna Therapeutics (1) · LMU Klinikum (1) · Myasthenia Gravis Foundation of America (1) · ProgenaBiome (1) · Zhongming Qiu (1)
United States (5) · Canada (3) · Germany (2) · Italy (2) · China (1) · France (1) · Poland (1) · Serbia (1) · Spain (1) · Turkey (Türkiye) (1) · United Kingdom (1)
Pauline Ducatel, Doctor (1) · Sabine Hazan, MD (1)